Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
  • Page of 1
Toro A, Lage-Vickers S, Bizzotto J, Vilicich F, Sabater A, Pascual G, Ledesma-Bazan S, Sanchis P, Ruiz MS, Arevalo AP, Porfido JL, Abbate M, Seniuk R, Labanca E, Anselmino N, Navone NM, Alonso DF, Vazquez E, Crispo M, Cotignola J, Gueron G. Pin-Pointing the Key Hubs in the IFN-γ Pathway Responding to SARS-CoV-2 Infection. Viruses. 2022 Sep 30;14(10). doi: 10.3390/v14102180. PubMed PMID: 36298734; PubMed Central PMCID: PMC9610092.
Sanchis P, Anselmino N, Lage-Vickers S, Sabater A, Lavignolle R, Labanca E, Shepherd PDA, Bizzotto J, Toro A, Mitrofanova A, Valacco MP, Navone N, Vazquez E, Cotignola J, Gueron G. Bone Progenitors Pull the Strings on the Early Metabolic Rewiring Occurring in Prostate Cancer Cells. Cancers (Basel). 2022 Apr 21;14(9). doi: 10.3390/cancers14092083. PubMed PMID: 35565211; PubMed Central PMCID: PMC9104818.
Labanca E, Yang J, Shepherd PDA, Wan X, Starbuck MW, Guerra LD, Anselmino N, Bizzotto JA, Dong J, Chinnaiyan AM, Ravoori MK, Kundra V, Broom BM, Corn PG, Troncoso P, Gueron G, Logothethis CJ, Navone NM. Fibroblast Growth Factor Receptor 1 Drives the Metastatic Progression of Prostate Cancer. Eur Urol Oncol. 2022 Apr;5(2):164-175. doi: 10.1016/j.euo.2021.10.001. Epub 2021 Nov 11. PubMed PMID: 34774481.
Lage-Vickers S, Sanchis P, Bizzotto J, Toro A, Sabater A, Lavignolle R, Anselmino N, Labanca E, Paez A, Navone N, Valacco MP, Cotignola J, Vazquez E, Gueron G. Exploiting Interdata Relationships in Prostate Cancer Proteomes: Clinical Significance of HO-1 Interactors. Antioxidants (Basel). 2022 Jan 31;11(2). doi: 10.3390/antiox11020290. PubMed PMID: 35204174; PubMed Central PMCID: PMC8868058.
Toro A, Ruiz MS, Lage-Vickers S, Sanchis P, Sabater A, Pascual G, Seniuk R, Cascardo F, Ledesma-Bazan S, Vilicich F, Vazquez E, Gueron G. A Journey into the Clinical Relevance of Heme Oxygenase 1 for Human Inflammatory Disease and Viral Clearance: Why Does It Matter on the COVID-19 Scene?. Antioxidants (Basel). 2022 Jan 29;11(2). doi: 10.3390/antiox11020276. Review. PubMed PMID: 35204159; PubMed Central PMCID: PMC8868141.
Labanca E, Bizzotto J, Sanchis P, Anselmino N, Yang J, Shepherd PDA, Paez A, Antico-Arciuch V, Lage-Vickers S, Hoang AG, Tang X, Raso MG, Titus M, Efstathiou E, Cotignola J, Araujo J, Logothetis C, Vazquez E, Navone N, Gueron G. Prostate cancer castrate resistant progression usage of non-canonical androgen receptor signaling and ketone body fuel. Oncogene. 2021 Nov;40(44):6284-6298. doi: 10.1038/s41388-021-02008-9. Epub 2021 Sep 28. PubMed PMID: 34584218; PubMed Central PMCID: PMC8566229.
Segatori VI, Garona J, Caligiuri LG, Bizzotto J, Lavignolle R, Toro A, Sanchis P, Spitzer E, Krolewiecki A, Gueron G, Alonso DF. Effect of Ivermectin and Atorvastatin on Nuclear Localization of Importin Alpha and Drug Target Expression Profiling in Host Cells from Nasopharyngeal Swabs of SARS-CoV-2- Positive Patients. Viruses. 2021 Oct 15;13(10). doi: 10.3390/v13102084. PubMed PMID: 34696514; PubMed Central PMCID: PMC8537229.
Araoz B, Karakaya E, González Wusener A, Detsch R, Bizzotto J, Gueron G, Boccaccini AR, Hermida ÉB. 3D printed poly (hydroxybutyrate-co-hydroxyvalerate)—45S5 bioactive glass composite resorbable scaffolds suitable for bone regeneration. Journal of Materials Research. 2021 June. doi:
Sanchis P, Lavignolle R, Abbate M, Lage-Vickers S, Vazquez E, Cotignola J, Bizzotto J, Gueron G. Analysis workflow of publicly available RNA-sequencing datasets. STAR Protoc. 2021 Jun 18;2(2):100478. doi: 10.1016/j.xpro.2021.100478. Epub 2021 Apr 22. PubMed PMID: 33907739; PubMed Central PMCID: PMC8061314.
Cascardo F, Anselmino N, Páez A, Labanca E, Sanchis P, Antico-Arciuch V, Navone N, Gueron G, Vázquez E, Cotignola J. HO-1 Modulates Aerobic Glycolysis through LDH in Prostate Cancer Cells. Antioxidants (Basel). 2021 Jun 16;10(6). doi: 10.3390/antiox10060966. PubMed PMID: 34208670; PubMed Central PMCID: PMC8235201.
Lage-Vickers S, Bizzotto J, Valacco MP, Sanchis P, Nemirovsky S, Labanca E, Scorticati C, Mazza O, Mitrofanova A, Navone N, Vazquez E, Cotignola J, Gueron G. The expression of YWHAZ and NDRG1 predicts aggressive outcome in human prostate cancer. Commun Biol. 2021 Jan 22;4(1):103. doi: 10.1038/s42003-020-01645-2. PubMed PMID: 33483585; PubMed Central PMCID: PMC7822895.
Senra D, Páez A, Gueron G, Bruno L, Guisoni N. Following the footprints of variability during filopodial growth. Eur Biophys J. 2020 Oct;49(7):643-659. doi: 10.1007/s00249-020-01473-6. Epub 2020 Nov 3. PubMed PMID: 33141270.
Bizzotto J, Sanchis P, Abbate M, Lage-Vickers S, Lavignolle R, Toro A, Olszevicki S, Sabater A, Cascardo F, Vazquez E, Cotignola J, Gueron G. SARS-CoV-2 Infection Boosts MX1 Antiviral Effector in COVID-19 Patients. iScience. 2020 Oct 23;23(10):101585. doi: 10.1016/j.isci.2020.101585. Epub 2020 Sep 23. PubMed PMID: 32989429; PubMed Central PMCID: PMC7510433.
Ortiz E, Sanchis P, Bizzotto J, Lage-Vickers S, Labanca E, Navone N, Cotignola J, Vazquez E, Gueron G. Myxovirus Resistance Protein 1 (MX1), a Novel HO-1 Interactor, Tilts the Balance of Endoplasmic Reticulum Stress towards Pro-Death Events in Prostate Cancer. Biomolecules. 2020 Jul 6;10(7). doi: 10.3390/biom10071005. PubMed PMID: 32640729; PubMed Central PMCID: PMC7407234.
Anselmino N, Starbuck M, Labanca E, Cotignola J, Navone N, Gueron G, Zenclussen AC, Vazquez E. Heme Oxygenase-1 Is a Pivotal Modulator of Bone Turnover and Remodeling: Molecular Implications for Prostate Cancer Bone Metastasis. Antioxid Redox Signal. 2020 Jun 10;32(17):1243-1258. doi: 10.1089/ars.2019.7879. Epub 2020 Jan 20. PubMed PMID: 31861963; PubMed Central PMCID: PMC7232646.
Anselmino N, Bizzotto J, Sanchis P, Lage-Vickers S, Ortiz E, Valacco P, Paez A, Labanca E, Meiss R, Navone N, Cotignola J, Vazquez E, Gueron G. HO-1 Interactors Involved in the Colonization of the Bone Niche: Role of ANXA2 in Prostate Cancer Progression. Biomolecules. 2020 Mar 18;10(3). doi: 10.3390/biom10030467. PubMed PMID: 32197509; PubMed Central PMCID: PMC7175266.
Ramakrishnan S, Granger V, Rak M, Hu Q, Attwood K, Aquila L, Krishnan N, Osiecki R, Azabdaftari G, Guru K, Chatta G, Gueron G, McNally L, Ohm J, Wang J, Woloszynska A. Inhibition of EZH2 induces NK cell-mediated differentiation and death in muscle-invasive bladder cancer. Cell Death Differ. 2019 Oct;26(10):2100-2114. doi: 10.1038/s41418-019-0278-9. Epub 2019 Jan 28. PubMed PMID: 30692641; PubMed Central PMCID: PMC6748105.
Dalton GN, Massillo C, Scalise GD, Duca R, Porretti J, Farré PL, Gardner K, Paez A, Gueron G, De Luca P, De Siervi A. CTBP1 depletion on prostate tumors deregulates miRNA/mRNA expression and impairs cancer progression in metabolic syndrome mice. Cell Death Dis. 2019 Apr 1;10(4):299. doi: 10.1038/s41419-019-1535-z. PubMed PMID: 30931931; PubMed Central PMCID: PMC6443782.
Leonardi DB, Anselmino N, Brandani JN, Jaworski FM, Páez AV, Mazaira G, Meiss RP, Nuñez M, Nemirovsky SI, Giudice J, Galigniana M, Pecci A, Gueron G, Vazquez E, Cotignola J. Heme Oxygenase 1 Impairs Glucocorticoid Receptor Activity in Prostate Cancer. Int J Mol Sci. 2019 Feb 26;20(5). doi: 10.3390/ijms20051006. PubMed PMID: 30813528; PubMed Central PMCID: PMC6429053.
Gueron G, Anselmino N, Chiarella P, Ortiz EG, Lage Vickers S, Paez AV, Giudice J, Contin MD, Leonardi D, Jaworski F, Manzano V, Strazza A, Montagna DR, Labanca E, Cotignola J, D Accorso N, Woloszynska-Read A, Navone N, Meiss RP, Ruggiero R, Vazquez E. Game-changing restraint of Ros-damaged phenylalanine, upon tumor metastasis. Cell Death Dis. 2018 Feb 2;9(2):140. doi: 10.1038/s41419-017-0147-8. PubMed PMID: 29396431; PubMed Central PMCID: PMC5833805.
Ramakrishnan S, Hu Q, Krishnan N, Wang D, Smit E, Granger V, Rak M, Attwood K, Johnson C, Morrison C, Pili R, Chatta G, Guru K, Gueron G, McNally L, Wang J, Woloszynska-Read A. Decitabine, a DNA-demethylating agent, promotes differentiation via NOTCH1 signaling and alters immune-related pathways in muscle-invasive bladder cancer. Cell Death Dis. 2017 Dec 14;8(12):3217. doi: 10.1038/s41419-017-0024-5. PubMed PMID: 29242529; PubMed Central PMCID: PMC5870579.
Antico VG, Gueron G, Cotignola J, Vazquez ES. Altered Signaling Pathways in Prostate Cancer Drive Metabolic Fate. INTERNATIONAL JOURNAL OF SCIENTIFIC RESEARCH. 2017 September; VI(IX):614.
Jaworski FM, Gentilini LD, Gueron G, Meiss RP, Ortiz EG, Berguer PM, Ahmed A, Navone N, Rabinovich GA, Compagno D, Laderach DJ, Vazquez ES. In Vivo Hemin Conditioning Targets the Vascular and Immunologic Compartments and Restrains Prostate Tumor Development. Clin Cancer Res. 2017 Sep 1;23(17):5135-5148. doi: 10.1158/1078-0432.CCR-17-0112. Epub 2017 May 16. PubMed PMID: 28512172.
Paez A, Vazquez E, Gueron G. Heme oxygenase 1 governs the cytoskeleton at filopodia: pulling the brakes on the migratory capacity of prostate tumoral cells. Cell Death Discov. 2017;3:17020. doi: 10.1038/cddiscovery.2017.20. eCollection 2017. PubMed PMID: 28417019; PubMed Central PMCID: PMC5377062.
Leonardi DB, Abbate M, Riccheri MC, Nuñez M, Alfonso G, Gueron G, De Siervi A, Vazquez E, Cotignola J. Improving risk stratification of patients with childhood acute lymphoblastic leukemia: Glutathione-S-Transferases polymorphisms are associated with increased risk of relapse. Oncotarget. 2017 Jan 3;8(1):110-117. doi: 10.18632/oncotarget.8606. PubMed PMID: 27058755; PubMed Central PMCID: PMC5352038.
Paez AV, Pallavicini C, Schuster F, Valacco MP, Giudice J, Ortiz EG, Anselmino N, Labanca E, Binaghi M, Salierno M, Martí MA, Cotignola JH, Woloszynska-Read A, Bruno L, Levi V, Navone N, Vazquez ES, Gueron G. Heme oxygenase-1 in the forefront of a multi-molecular network that governs cell-cell contacts and filopodia-induced zippering in prostate cancer. Cell Death Dis. 2016 Dec 29;7(12):e2570. doi: 10.1038/cddis.2016.420. PubMed PMID: 28032857; PubMed Central PMCID: PMC5261017.
Labanca E, De Luca P, Gueron G, Paez A, Moiola CP, Massillo C, Porretti J, Giudice J, Zalazar F, Navone N, Vazquez E, De Siervi A. Association of HO-1 and BRCA1 Is Critical for the Maintenance of Cellular Homeostasis in Prostate Cancer. Mol Cancer Res. 2015 Nov;13(11):1455-64. doi: 10.1158/1541-7786.MCR-15-0150-T. Epub 2015 Jul 30. PubMed PMID: 26227317.
Ahmad S, Hewett PW, Fujisawa T, Sissaoui S, Cai M, Gueron G, Al-Ani B, Cudmore M, Ahmed SF, Wong MK, Wegiel B, Otterbein LE, Vítek L, Ramma W, Wang K, Ahmed A. Carbon monoxide inhibits sprouting angiogenesis and vascular endothelial growth factor receptor-2 phosphorylation. Thromb Haemost. 2015 Feb;113(2):329-37. doi: 10.1160/TH14-01-0002. Epub 2014 Oct 30. PubMed PMID: 25354586.
Gueron G, Avanzo RE, Schuster F, Carabelos MN, Vazquez E, Fascio ML, D'Accorso NB. Differential effect of heterocyclic D-ribofuranoside derivatives on human prostate cancer cell viability and cell cycle progression. Biomed Pharmacother. 2014 Sep;68(7):847-54. doi: 10.1016/j.biopha.2014.08.010. Epub 2014 Aug 19. PubMed PMID: 25217395.
Gueron G, Giudice J, Valacco P, Paez A, Elguero B, Toscani M, Jaworski F, Leskow FC, Cotignola J, Marti M, Binaghi M, Navone N, Vazquez E. Heme-oxygenase-1 implications in cell morphology and the adhesive behavior of prostate cancer cells. Oncotarget. 2014 Jun 30;5(12):4087-102. doi: 10.18632/oncotarget.1826. PubMed PMID: 24961479; PubMed Central PMCID: PMC4147308.
Elguero B, Gueron G, Giudice J, Toscani MA, De Luca P, Zalazar F, Coluccio-Leskow F, Meiss R, Navone N, De Siervi A, Vazquez E. Unveiling the association of STAT3 and HO-1 in prostate cancer: role beyond heme degradation. Neoplasia. 2012 Nov;14(11):1043-56. doi: 10.1593/neo.121358. PubMed PMID: 23226098; PubMed Central PMCID: PMC3514752.
Gueron G, De Siervi A, Vazquez E. Advanced prostate cancer: reinforcing the strings between inflammation and the metastatic behavior. Prostate Cancer Prostatic Dis. 2012 Sep;15(3):213-21. doi: 10.1038/pcan.2011.64. Epub 2011 Dec 20. Review. PubMed PMID: 22183772.
Ferrando M, Gueron G, Elguero B, Giudice J, Salles A, Leskow FC, Jares-Erijman EA, Colombo L, Meiss R, Navone N, De Siervi A, Vazquez E. Heme oxygenase 1 (HO-1) challenges the angiogenic switch in prostate cancer. Angiogenesis. 2011 Dec;14(4):467-79. doi: 10.1007/s10456-011-9230-4. Epub 2011 Aug 11. PubMed PMID: 21833623.
Gueron G, De Siervi A, Vazquez E. Key questions in metastasis: new insights in molecular pathways and therapeutic implications. Curr Pharm Biotechnol. 2011 Nov;12(11):1867-80. doi: 10.2174/138920111798376996. Review. PubMed PMID: 21470130.
De Luca P, Vazquez ES, Moiola CP, Zalazar F, Cotignola J, Gueron G, Gardner K, De Siervi A. BRCA1 loss induces GADD153-mediated doxorubicin resistance in prostate cancer. Mol Cancer Res. 2011 Aug;9(8):1078-90. doi: 10.1158/1541-7786.MCR-11-0155. Epub 2011 Jun 23. PubMed PMID: 21700680; PubMed Central PMCID: PMC6959536.
Gueron G, De Siervi A, Ferrando M, Salierno M, De Luca P, Elguero B, Meiss R, Navone N, Vazquez ES. Critical role of endogenous heme oxygenase 1 as a tuner of the invasive potential of prostate cancer cells. Mol Cancer Res. 2009 Nov;7(11):1745-55. doi: 10.1158/1541-7786.MCR-08-0325. Epub 2009 Nov 10. PubMed PMID: 19903769.
De Siervi A, De Luca P, Moiola C, Gueron G, Tongbai R, Chandramouli GV, Haggerty C, Dzekunova I, Petersen D, Kawasaki E, Kil WJ, Camphausen K, Longo D, Gardner K. Identification of new Rel/NFkappaB regulatory networks by focused genome location analysis. Cell Cycle. 2009 Jul 1;8(13):2093-100. doi: 10.4161/cc.8.13.8926. Epub 2009 Jul 5. PubMed PMID: 19502793; PubMed Central PMCID: PMC2809250.
Ge Y, Byun JS, De Luca P, Gueron G, Yabe IM, Sadiq-Ali SG, Figg WD, Quintero J, Haggerty CM, Li QQ, De Siervi A, Gardner K. Combinatorial antileukemic disruption of oxidative homeostasis and mitochondrial stability by the redox reactive thalidomide 2-(2,4-difluoro-phenyl)-4,5,6,7-tetrafluoro-1H-isoindole-1,3(2H)-dione (CPS49) and flavopiridol. Mol Pharmacol. 2008 Sep;74(3):872-83. doi: 10.1124/mol.107.040808. Epub 2008 Jun 12. PubMed PMID: 18556456; PubMed Central PMCID: PMC2778846.
What would you like to do?
  • Page of 1